nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—malignant glioma	0.609	1	CbGaD
Ropivacaine—CYP1A2—Carmustine—malignant glioma	0.103	0.57	CbGbCtD
Ropivacaine—CYP3A4—Temozolomide—malignant glioma	0.0778	0.431	CbGbCtD
Ropivacaine—SCN8A—cerebellar cortex—malignant glioma	0.0163	0.245	CbGeAlD
Ropivacaine—Vasospasm—Carmustine—malignant glioma	0.00361	0.0359	CcSEcCtD
Ropivacaine—Paresis—Temozolomide—malignant glioma	0.00327	0.0325	CcSEcCtD
Ropivacaine—Meningitis—Carmustine—malignant glioma	0.00318	0.0316	CcSEcCtD
Ropivacaine—Grand mal convulsion—Carmustine—malignant glioma	0.00259	0.0257	CcSEcCtD
Ropivacaine—SCN8A—brainstem—malignant glioma	0.00257	0.0386	CbGeAlD
Ropivacaine—Faecal incontinence—Carmustine—malignant glioma	0.00244	0.0243	CcSEcCtD
Ropivacaine—Faecal incontinence—Temozolomide—malignant glioma	0.00236	0.0235	CcSEcCtD
Ropivacaine—SCN8A—telencephalon—malignant glioma	0.00228	0.0342	CbGeAlD
Ropivacaine—Deep vein thrombosis—Temozolomide—malignant glioma	0.00196	0.0195	CcSEcCtD
Ropivacaine—SCN1A—brainstem—malignant glioma	0.00194	0.0292	CbGeAlD
Ropivacaine—Hypokinesia—Carmustine—malignant glioma	0.00183	0.0182	CcSEcCtD
Ropivacaine—SCN2A—brainstem—malignant glioma	0.00178	0.0268	CbGeAlD
Ropivacaine—SCN1A—telencephalon—malignant glioma	0.00173	0.0259	CbGeAlD
Ropivacaine—Stupor—Carmustine—malignant glioma	0.00165	0.0164	CcSEcCtD
Ropivacaine—SCN8A—spinal cord—malignant glioma	0.0016	0.024	CbGeAlD
Ropivacaine—SCN2A—telencephalon—malignant glioma	0.00158	0.0238	CbGeAlD
Ropivacaine—SCN10A—telencephalon—malignant glioma	0.00153	0.0229	CbGeAlD
Ropivacaine—Injection site pain—Carmustine—malignant glioma	0.00151	0.015	CcSEcCtD
Ropivacaine—Rigors—Temozolomide—malignant glioma	0.00146	0.0145	CcSEcCtD
Ropivacaine—SCN9A—midbrain—malignant glioma	0.00144	0.0216	CbGeAlD
Ropivacaine—SCN9A—spinal cord—malignant glioma	0.00141	0.0211	CbGeAlD
Ropivacaine—SCN3A—telencephalon—malignant glioma	0.00139	0.0209	CbGeAlD
Ropivacaine—SCN1A—medulla oblongata—malignant glioma	0.00136	0.0203	CbGeAlD
Ropivacaine—Lidocaine—CYP2C18—malignant glioma	0.00132	0.396	CrCbGaD
Ropivacaine—Leukocytosis—Carmustine—malignant glioma	0.00131	0.013	CcSEcCtD
Ropivacaine—SCN8A—central nervous system—malignant glioma	0.0013	0.0195	CbGeAlD
Ropivacaine—SCN8A—cerebellum—malignant glioma	0.00127	0.019	CbGeAlD
Ropivacaine—SCN2A—medulla oblongata—malignant glioma	0.00124	0.0187	CbGeAlD
Ropivacaine—SCN1A—midbrain—malignant glioma	0.00124	0.0186	CbGeAlD
Ropivacaine—Pulmonary embolism—Carmustine—malignant glioma	0.00123	0.0123	CcSEcCtD
Ropivacaine—Injection site reaction—Carmustine—malignant glioma	0.00123	0.0122	CcSEcCtD
Ropivacaine—Respiratory failure—Temozolomide—malignant glioma	0.00121	0.0121	CcSEcCtD
Ropivacaine—SCN1A—spinal cord—malignant glioma	0.00121	0.0181	CbGeAlD
Ropivacaine—Pulmonary embolism—Temozolomide—malignant glioma	0.00119	0.0118	CcSEcCtD
Ropivacaine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00119	0.0118	CcSEcCtD
Ropivacaine—Urinary incontinence—Carmustine—malignant glioma	0.00119	0.0118	CcSEcCtD
Ropivacaine—Depressed level of consciousness—Carmustine—malignant glioma	0.00119	0.0118	CcSEcCtD
Ropivacaine—Neuropathy—Carmustine—malignant glioma	0.00116	0.0115	CcSEcCtD
Ropivacaine—Urinary incontinence—Temozolomide—malignant glioma	0.00115	0.0114	CcSEcCtD
Ropivacaine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00115	0.0114	CcSEcCtD
Ropivacaine—SCN2A—midbrain—malignant glioma	0.00114	0.0171	CbGeAlD
Ropivacaine—Coma—Carmustine—malignant glioma	0.00113	0.0112	CcSEcCtD
Ropivacaine—Neuropathy—Temozolomide—malignant glioma	0.00112	0.0111	CcSEcCtD
Ropivacaine—SCN2A—spinal cord—malignant glioma	0.00111	0.0166	CbGeAlD
Ropivacaine—SCN3A—medulla oblongata—malignant glioma	0.00109	0.0164	CbGeAlD
Ropivacaine—SCN10A—spinal cord—malignant glioma	0.00107	0.016	CbGeAlD
Ropivacaine—Phlebitis—Carmustine—malignant glioma	0.00104	0.0103	CcSEcCtD
Ropivacaine—Lidocaine—EGFR—malignant glioma	0.00103	0.309	CrCbGaD
Ropivacaine—SCN8A—brain—malignant glioma	0.00103	0.0154	CbGeAlD
Ropivacaine—SCN4A—central nervous system—malignant glioma	0.00102	0.0153	CbGeAlD
Ropivacaine—SCN3A—midbrain—malignant glioma	0.001	0.015	CbGeAlD
Ropivacaine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000994	0.00988	CcSEcCtD
Ropivacaine—Lidocaine—CYP2B6—malignant glioma	0.000982	0.294	CrCbGaD
Ropivacaine—SCN1A—central nervous system—malignant glioma	0.000981	0.0147	CbGeAlD
Ropivacaine—SCN3A—spinal cord—malignant glioma	0.000975	0.0146	CbGeAlD
Ropivacaine—Vascular purpura—Temozolomide—malignant glioma	0.000967	0.00961	CcSEcCtD
Ropivacaine—SCN1A—cerebellum—malignant glioma	0.000959	0.0144	CbGeAlD
Ropivacaine—Amnesia—Carmustine—malignant glioma	0.000953	0.00947	CcSEcCtD
Ropivacaine—Amnesia—Temozolomide—malignant glioma	0.000921	0.00915	CcSEcCtD
Ropivacaine—SCN9A—brain—malignant glioma	0.000905	0.0136	CbGeAlD
Ropivacaine—SCN2A—central nervous system—malignant glioma	0.0009	0.0135	CbGeAlD
Ropivacaine—Purpura—Temozolomide—malignant glioma	0.000897	0.00892	CcSEcCtD
Ropivacaine—SCN2A—cerebellum—malignant glioma	0.00088	0.0132	CbGeAlD
Ropivacaine—SCN10A—central nervous system—malignant glioma	0.000868	0.013	CbGeAlD
Ropivacaine—Affect lability—Temozolomide—malignant glioma	0.000851	0.00846	CcSEcCtD
Ropivacaine—Mood swings—Temozolomide—malignant glioma	0.000819	0.00814	CcSEcCtD
Ropivacaine—Hypokalaemia—Carmustine—malignant glioma	0.000815	0.0081	CcSEcCtD
Ropivacaine—SCN4A—brain—malignant glioma	0.000808	0.0121	CbGeAlD
Ropivacaine—SCN3A—central nervous system—malignant glioma	0.000791	0.0119	CbGeAlD
Ropivacaine—SCN5A—central nervous system—malignant glioma	0.000789	0.0118	CbGeAlD
Ropivacaine—Hypokalaemia—Temozolomide—malignant glioma	0.000787	0.00782	CcSEcCtD
Ropivacaine—Breast disorder—Temozolomide—malignant glioma	0.000782	0.00777	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000779	0.00774	CcSEcCtD
Ropivacaine—SCN1A—brain—malignant glioma	0.000779	0.0117	CbGeAlD
Ropivacaine—SCN3A—cerebellum—malignant glioma	0.000773	0.0116	CbGeAlD
Ropivacaine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000763	0.00758	CcSEcCtD
Ropivacaine—Abdominal distension—Temozolomide—malignant glioma	0.000753	0.00748	CcSEcCtD
Ropivacaine—Sweating increased—Temozolomide—malignant glioma	0.000728	0.00724	CcSEcCtD
Ropivacaine—SCN2A—brain—malignant glioma	0.000715	0.0107	CbGeAlD
Ropivacaine—Dysuria—Temozolomide—malignant glioma	0.000699	0.00695	CcSEcCtD
Ropivacaine—Hyperglycaemia—Carmustine—malignant glioma	0.000698	0.00694	CcSEcCtD
Ropivacaine—SCN10A—brain—malignant glioma	0.000689	0.0103	CbGeAlD
Ropivacaine—Depression—Carmustine—malignant glioma	0.000688	0.00684	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Carmustine—malignant glioma	0.000676	0.00672	CcSEcCtD
Ropivacaine—Hyperglycaemia—Temozolomide—malignant glioma	0.000674	0.0067	CcSEcCtD
Ropivacaine—Urinary tract infection—Carmustine—malignant glioma	0.00067	0.00666	CcSEcCtD
Ropivacaine—Depression—Temozolomide—malignant glioma	0.000665	0.00661	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000653	0.00649	CcSEcCtD
Ropivacaine—Urinary tract infection—Temozolomide—malignant glioma	0.000648	0.00644	CcSEcCtD
Ropivacaine—SCN3A—brain—malignant glioma	0.000628	0.00942	CbGeAlD
Ropivacaine—SCN5A—brain—malignant glioma	0.000626	0.00939	CbGeAlD
Ropivacaine—Hallucination—Carmustine—malignant glioma	0.000616	0.00612	CcSEcCtD
Ropivacaine—Hypoaesthesia—Carmustine—malignant glioma	0.000616	0.00612	CcSEcCtD
Ropivacaine—Oedema peripheral—Carmustine—malignant glioma	0.00061	0.00606	CcSEcCtD
Ropivacaine—Hallucination—Temozolomide—malignant glioma	0.000595	0.00592	CcSEcCtD
Ropivacaine—Hypoaesthesia—Temozolomide—malignant glioma	0.000595	0.00592	CcSEcCtD
Ropivacaine—Urinary tract disorder—Temozolomide—malignant glioma	0.000591	0.00587	CcSEcCtD
Ropivacaine—Oedema peripheral—Temozolomide—malignant glioma	0.000589	0.00586	CcSEcCtD
Ropivacaine—Urethral disorder—Temozolomide—malignant glioma	0.000587	0.00583	CcSEcCtD
Ropivacaine—CYP2D6—brainstem—malignant glioma	0.000586	0.0088	CbGeAlD
Ropivacaine—Tinnitus—Temozolomide—malignant glioma	0.000558	0.00555	CcSEcCtD
Ropivacaine—Cardiac disorder—Temozolomide—malignant glioma	0.000555	0.00552	CcSEcCtD
Ropivacaine—Arrhythmia—Carmustine—malignant glioma	0.000553	0.0055	CcSEcCtD
Ropivacaine—Mental disorder—Carmustine—malignant glioma	0.000542	0.00539	CcSEcCtD
Ropivacaine—Erythema—Carmustine—malignant glioma	0.000539	0.00536	CcSEcCtD
Ropivacaine—Chills—Temozolomide—malignant glioma	0.000537	0.00534	CcSEcCtD
Ropivacaine—Mental disorder—Temozolomide—malignant glioma	0.000524	0.00521	CcSEcCtD
Ropivacaine—Back pain—Carmustine—malignant glioma	0.000521	0.00518	CcSEcCtD
Ropivacaine—Erythema—Temozolomide—malignant glioma	0.000521	0.00518	CcSEcCtD
Ropivacaine—CYP2D6—telencephalon—malignant glioma	0.00052	0.00781	CbGeAlD
Ropivacaine—Vision blurred—Carmustine—malignant glioma	0.000508	0.00505	CcSEcCtD
Ropivacaine—Tremor—Carmustine—malignant glioma	0.000505	0.00502	CcSEcCtD
Ropivacaine—Back pain—Temozolomide—malignant glioma	0.000504	0.00501	CcSEcCtD
Ropivacaine—Anaemia—Carmustine—malignant glioma	0.000498	0.00495	CcSEcCtD
Ropivacaine—Agitation—Carmustine—malignant glioma	0.000495	0.00492	CcSEcCtD
Ropivacaine—Vision blurred—Temozolomide—malignant glioma	0.000491	0.00488	CcSEcCtD
Ropivacaine—Tremor—Temozolomide—malignant glioma	0.000488	0.00485	CcSEcCtD
Ropivacaine—Ill-defined disorder—Temozolomide—malignant glioma	0.000483	0.0048	CcSEcCtD
Ropivacaine—Anaemia—Temozolomide—malignant glioma	0.000481	0.00479	CcSEcCtD
Ropivacaine—Agitation—Temozolomide—malignant glioma	0.000479	0.00476	CcSEcCtD
Ropivacaine—Angioedema—Temozolomide—malignant glioma	0.000476	0.00473	CcSEcCtD
Ropivacaine—Malaise—Temozolomide—malignant glioma	0.00047	0.00467	CcSEcCtD
Ropivacaine—Vertigo—Temozolomide—malignant glioma	0.000468	0.00465	CcSEcCtD
Ropivacaine—Convulsion—Carmustine—malignant glioma	0.000467	0.00464	CcSEcCtD
Ropivacaine—Hypertension—Carmustine—malignant glioma	0.000465	0.00463	CcSEcCtD
Ropivacaine—Myalgia—Carmustine—malignant glioma	0.000459	0.00456	CcSEcCtD
Ropivacaine—Chest pain—Carmustine—malignant glioma	0.000459	0.00456	CcSEcCtD
Ropivacaine—Anxiety—Carmustine—malignant glioma	0.000457	0.00455	CcSEcCtD
Ropivacaine—Cough—Temozolomide—malignant glioma	0.000455	0.00452	CcSEcCtD
Ropivacaine—Convulsion—Temozolomide—malignant glioma	0.000451	0.00449	CcSEcCtD
Ropivacaine—Hypertension—Temozolomide—malignant glioma	0.00045	0.00447	CcSEcCtD
Ropivacaine—Confusional state—Carmustine—malignant glioma	0.000444	0.00441	CcSEcCtD
Ropivacaine—Myalgia—Temozolomide—malignant glioma	0.000443	0.00441	CcSEcCtD
Ropivacaine—Arthralgia—Temozolomide—malignant glioma	0.000443	0.00441	CcSEcCtD
Ropivacaine—Anxiety—Temozolomide—malignant glioma	0.000442	0.00439	CcSEcCtD
Ropivacaine—Discomfort—Temozolomide—malignant glioma	0.000438	0.00436	CcSEcCtD
Ropivacaine—Infection—Carmustine—malignant glioma	0.000437	0.00434	CcSEcCtD
Ropivacaine—Thrombocytopenia—Carmustine—malignant glioma	0.000431	0.00428	CcSEcCtD
Ropivacaine—Tachycardia—Carmustine—malignant glioma	0.000429	0.00427	CcSEcCtD
Ropivacaine—Confusional state—Temozolomide—malignant glioma	0.000429	0.00426	CcSEcCtD
Ropivacaine—Anaphylactic shock—Temozolomide—malignant glioma	0.000425	0.00423	CcSEcCtD
Ropivacaine—Infection—Temozolomide—malignant glioma	0.000422	0.0042	CcSEcCtD
Ropivacaine—Thrombocytopenia—Temozolomide—malignant glioma	0.000416	0.00414	CcSEcCtD
Ropivacaine—Skin disorder—Temozolomide—malignant glioma	0.000413	0.0041	CcSEcCtD
Ropivacaine—Hypotension—Carmustine—malignant glioma	0.000411	0.00409	CcSEcCtD
Ropivacaine—Hyperhidrosis—Temozolomide—malignant glioma	0.000411	0.00409	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000401	0.00398	CcSEcCtD
Ropivacaine—CYP2B6—central nervous system—malignant glioma	0.000398	0.00597	CbGeAlD
Ropivacaine—Insomnia—Carmustine—malignant glioma	0.000398	0.00395	CcSEcCtD
Ropivacaine—Paraesthesia—Carmustine—malignant glioma	0.000395	0.00393	CcSEcCtD
Ropivacaine—Dyspnoea—Carmustine—malignant glioma	0.000392	0.0039	CcSEcCtD
Ropivacaine—Somnolence—Carmustine—malignant glioma	0.000391	0.00389	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000387	0.00385	CcSEcCtD
Ropivacaine—Insomnia—Temozolomide—malignant glioma	0.000385	0.00382	CcSEcCtD
Ropivacaine—Paraesthesia—Temozolomide—malignant glioma	0.000382	0.00379	CcSEcCtD
Ropivacaine—Dyspnoea—Temozolomide—malignant glioma	0.000379	0.00377	CcSEcCtD
Ropivacaine—Somnolence—Temozolomide—malignant glioma	0.000378	0.00376	CcSEcCtD
Ropivacaine—Constipation—Carmustine—malignant glioma	0.000376	0.00374	CcSEcCtD
Ropivacaine—Pain—Carmustine—malignant glioma	0.000376	0.00374	CcSEcCtD
Ropivacaine—Dyspepsia—Temozolomide—malignant glioma	0.000374	0.00372	CcSEcCtD
Ropivacaine—Constipation—Temozolomide—malignant glioma	0.000364	0.00361	CcSEcCtD
Ropivacaine—Pain—Temozolomide—malignant glioma	0.000364	0.00361	CcSEcCtD
Ropivacaine—Feeling abnormal—Carmustine—malignant glioma	0.000363	0.0036	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Carmustine—malignant glioma	0.00036	0.00358	CcSEcCtD
Ropivacaine—Feeling abnormal—Temozolomide—malignant glioma	0.00035	0.00348	CcSEcCtD
Ropivacaine—Body temperature increased—Carmustine—malignant glioma	0.000348	0.00346	CcSEcCtD
Ropivacaine—Abdominal pain—Carmustine—malignant glioma	0.000348	0.00346	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000348	0.00346	CcSEcCtD
Ropivacaine—Urticaria—Temozolomide—malignant glioma	0.000338	0.00336	CcSEcCtD
Ropivacaine—Abdominal pain—Temozolomide—malignant glioma	0.000336	0.00334	CcSEcCtD
Ropivacaine—Body temperature increased—Temozolomide—malignant glioma	0.000336	0.00334	CcSEcCtD
Ropivacaine—Hypersensitivity—Carmustine—malignant glioma	0.000324	0.00322	CcSEcCtD
Ropivacaine—CYP2B6—brain—malignant glioma	0.000316	0.00474	CbGeAlD
Ropivacaine—Asthenia—Carmustine—malignant glioma	0.000316	0.00314	CcSEcCtD
Ropivacaine—Hypersensitivity—Temozolomide—malignant glioma	0.000313	0.00311	CcSEcCtD
Ropivacaine—Asthenia—Temozolomide—malignant glioma	0.000305	0.00303	CcSEcCtD
Ropivacaine—Diarrhoea—Carmustine—malignant glioma	0.000301	0.00299	CcSEcCtD
Ropivacaine—Pruritus—Temozolomide—malignant glioma	0.000301	0.00299	CcSEcCtD
Ropivacaine—CYP3A4—central nervous system—malignant glioma	0.000301	0.00451	CbGeAlD
Ropivacaine—CYP2D6—central nervous system—malignant glioma	0.000296	0.00444	CbGeAlD
Ropivacaine—Dizziness—Carmustine—malignant glioma	0.000291	0.00289	CcSEcCtD
Ropivacaine—Diarrhoea—Temozolomide—malignant glioma	0.000291	0.00289	CcSEcCtD
Ropivacaine—CYP2D6—cerebellum—malignant glioma	0.000289	0.00434	CbGeAlD
Ropivacaine—Dizziness—Temozolomide—malignant glioma	0.000281	0.00279	CcSEcCtD
Ropivacaine—Vomiting—Carmustine—malignant glioma	0.00028	0.00278	CcSEcCtD
Ropivacaine—Rash—Carmustine—malignant glioma	0.000277	0.00276	CcSEcCtD
Ropivacaine—Dermatitis—Carmustine—malignant glioma	0.000277	0.00275	CcSEcCtD
Ropivacaine—Headache—Carmustine—malignant glioma	0.000276	0.00274	CcSEcCtD
Ropivacaine—Vomiting—Temozolomide—malignant glioma	0.00027	0.00269	CcSEcCtD
Ropivacaine—Rash—Temozolomide—malignant glioma	0.000268	0.00266	CcSEcCtD
Ropivacaine—Dermatitis—Temozolomide—malignant glioma	0.000268	0.00266	CcSEcCtD
Ropivacaine—Headache—Temozolomide—malignant glioma	0.000266	0.00265	CcSEcCtD
Ropivacaine—Nausea—Carmustine—malignant glioma	0.000261	0.0026	CcSEcCtD
Ropivacaine—Nausea—Temozolomide—malignant glioma	0.000253	0.00251	CcSEcCtD
Ropivacaine—CYP2D6—brain—malignant glioma	0.000235	0.00352	CbGeAlD
Ropivacaine—SCN1A—Axon guidance—MMP9—malignant glioma	4.43e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MMP9—malignant glioma	4.41e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP2—malignant glioma	4.36e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP2—malignant glioma	4.36e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT2—malignant glioma	4.34e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT2—malignant glioma	4.34e-05	0.0011	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTT1—malignant glioma	4.33e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—FGF2—malignant glioma	4.31e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—malignant glioma	4.3e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—malignant glioma	4.29e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP2—malignant glioma	4.21e-05	0.00107	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP2—malignant glioma	4.21e-05	0.00107	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—RAF1—malignant glioma	4.2e-05	0.00107	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	4.18e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—ERBB2—malignant glioma	4.16e-05	0.00105	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	4.15e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP2—malignant glioma	4.14e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—FGF2—malignant glioma	4.14e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—FGF2—malignant glioma	4.14e-05	0.00105	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	4.14e-05	0.00105	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	4.13e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—malignant glioma	4.13e-05	0.00105	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—malignant glioma	4.13e-05	0.00105	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	4.08e-05	0.00103	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—PTGS1—malignant glioma	4.06e-05	0.00103	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—malignant glioma	4.04e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—RAF1—malignant glioma	4.02e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—FGF2—malignant glioma	4e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—FGF2—malignant glioma	4e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—ERBB2—malignant glioma	3.98e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—malignant glioma	3.98e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—malignant glioma	3.98e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—malignant glioma	3.96e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—STAT3—malignant glioma	3.92e-05	0.000994	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—malignant glioma	3.87e-05	0.00098	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—RAF1—malignant glioma	3.86e-05	0.000979	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—RAF1—malignant glioma	3.86e-05	0.000979	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—FGFR1—malignant glioma	3.85e-05	0.000975	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ERBB2—malignant glioma	3.82e-05	0.000969	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—ERBB2—malignant glioma	3.82e-05	0.000969	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—KRAS—malignant glioma	3.82e-05	0.000967	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—RAF1—malignant glioma	3.73e-05	0.000944	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—RAF1—malignant glioma	3.73e-05	0.000944	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—malignant glioma	3.71e-05	0.000941	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—malignant glioma	3.71e-05	0.000941	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—ERBB2—malignant glioma	3.69e-05	0.000934	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ERBB2—malignant glioma	3.69e-05	0.000934	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—RAF1—malignant glioma	3.67e-05	0.00093	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—KRAS—malignant glioma	3.65e-05	0.000925	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ERBB2—malignant glioma	3.63e-05	0.00092	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KDR—malignant glioma	3.62e-05	0.000918	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—RTEL1—malignant glioma	3.58e-05	0.000908	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—malignant glioma	3.58e-05	0.000907	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—malignant glioma	3.58e-05	0.000907	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	3.58e-05	0.000906	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP9—malignant glioma	3.57e-05	0.000904	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—malignant glioma	3.57e-05	0.000904	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MET—malignant glioma	3.55e-05	0.000899	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	3.54e-05	0.000898	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	3.52e-05	0.000892	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—KRAS—malignant glioma	3.51e-05	0.000889	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—KRAS—malignant glioma	3.51e-05	0.000889	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	3.49e-05	0.000886	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NOTCH1—malignant glioma	3.41e-05	0.000865	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP9—malignant glioma	3.41e-05	0.000865	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—malignant glioma	3.4e-05	0.000861	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—KRAS—malignant glioma	3.38e-05	0.000857	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—KRAS—malignant glioma	3.38e-05	0.000857	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—KRAS—malignant glioma	3.37e-05	0.000854	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	3.34e-05	0.000847	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PTPN11—malignant glioma	3.28e-05	0.000831	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP9—malignant glioma	3.28e-05	0.000831	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP9—malignant glioma	3.28e-05	0.000831	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	3.24e-05	0.00082	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PPARG—malignant glioma	3.22e-05	0.000816	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—malignant glioma	3.2e-05	0.000812	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—STAT3—malignant glioma	3.17e-05	0.000804	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	3.17e-05	0.000802	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	3.17e-05	0.000802	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—malignant glioma	3.16e-05	0.000801	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—malignant glioma	3.16e-05	0.000801	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	3.13e-05	0.000794	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—malignant glioma	3.12e-05	0.000789	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—malignant glioma	3.06e-05	0.000777	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT2—malignant glioma	3.05e-05	0.000774	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—STAT3—malignant glioma	3.03e-05	0.000769	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—RTEL1—malignant glioma	3.03e-05	0.000769	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	3.01e-05	0.000764	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	3.01e-05	0.000764	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTP1—malignant glioma	3e-05	0.000761	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	2.99e-05	0.000758	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—COX8A—malignant glioma	2.96e-05	0.00075	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	2.96e-05	0.00075	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP2—malignant glioma	2.96e-05	0.00075	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—malignant glioma	2.94e-05	0.000746	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—malignant glioma	2.94e-05	0.000746	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—STAT3—malignant glioma	2.92e-05	0.000739	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—STAT3—malignant glioma	2.92e-05	0.000739	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—malignant glioma	2.88e-05	0.000731	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—malignant glioma	2.84e-05	0.00072	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—malignant glioma	2.84e-05	0.00072	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—STAT3—malignant glioma	2.81e-05	0.000712	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—STAT3—malignant glioma	2.81e-05	0.000712	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—FGF2—malignant glioma	2.81e-05	0.000712	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—malignant glioma	2.8e-05	0.000709	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—malignant glioma	2.76e-05	0.000699	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—malignant glioma	2.75e-05	0.000696	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—malignant glioma	2.72e-05	0.00069	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—malignant glioma	2.65e-05	0.000672	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—malignant glioma	2.65e-05	0.000672	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—malignant glioma	2.63e-05	0.000666	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—RAF1—malignant glioma	2.62e-05	0.000664	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—malignant glioma	2.61e-05	0.00066	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—malignant glioma	2.59e-05	0.000657	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—malignant glioma	2.56e-05	0.000648	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—malignant glioma	2.56e-05	0.000648	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—malignant glioma	2.53e-05	0.000641	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—malignant glioma	2.52e-05	0.00064	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—malignant glioma	2.52e-05	0.00064	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—malignant glioma	2.52e-05	0.000638	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ASMT—malignant glioma	2.52e-05	0.000638	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—malignant glioma	2.5e-05	0.000634	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—malignant glioma	2.5e-05	0.000634	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—malignant glioma	2.43e-05	0.000617	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—malignant glioma	2.43e-05	0.000617	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—malignant glioma	2.41e-05	0.000612	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—malignant glioma	2.41e-05	0.000612	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—malignant glioma	2.38e-05	0.000603	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BCAN—malignant glioma	2.37e-05	0.0006	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—RTEL1—malignant glioma	2.34e-05	0.000594	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	2.32e-05	0.000587	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.28e-05	0.000579	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—malignant glioma	2.22e-05	0.000563	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.17e-05	0.00055	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.1e-05	0.000532	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—COX8A—malignant glioma	2.06e-05	0.000521	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—malignant glioma	2.04e-05	0.000518	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—malignant glioma	2e-05	0.000506	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—malignant glioma	1.98e-05	0.000501	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—malignant glioma	1.96e-05	0.000496	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—IDH2—malignant glioma	1.91e-05	0.000483	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—malignant glioma	1.88e-05	0.000476	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—malignant glioma	1.88e-05	0.000476	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—malignant glioma	1.81e-05	0.000459	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—malignant glioma	1.81e-05	0.000459	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—malignant glioma	1.8e-05	0.000455	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ASMT—malignant glioma	1.75e-05	0.000443	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—COX8A—malignant glioma	1.74e-05	0.000442	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—malignant glioma	1.71e-05	0.000434	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—malignant glioma	1.7e-05	0.00043	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BCAN—malignant glioma	1.64e-05	0.000417	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—IDH1—malignant glioma	1.64e-05	0.000416	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SPHK1—malignant glioma	1.59e-05	0.000402	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.56e-05	0.000395	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.55e-05	0.000394	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ASMT—malignant glioma	1.48e-05	0.000376	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.45e-05	0.000367	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BCAN—malignant glioma	1.39e-05	0.000353	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—COX8A—malignant glioma	1.35e-05	0.000341	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—IDH2—malignant glioma	1.33e-05	0.000336	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—malignant glioma	1.27e-05	0.000323	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTT1—malignant glioma	1.26e-05	0.000319	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.25e-05	0.000316	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS1—malignant glioma	1.18e-05	0.000299	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ASMT—malignant glioma	1.14e-05	0.00029	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—IDH1—malignant glioma	1.14e-05	0.000289	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—IDH2—malignant glioma	1.12e-05	0.000285	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.1e-05	0.00028	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BCHE—malignant glioma	1.1e-05	0.000278	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.08e-05	0.000274	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.08e-05	0.000274	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BCAN—malignant glioma	1.08e-05	0.000273	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.06e-05	0.000268	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.06e-05	0.000268	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—IDH1—malignant glioma	9.66e-06	0.000245	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SPHK1—malignant glioma	9.35e-06	0.000237	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP2C18—malignant glioma	9.16e-06	0.000232	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTT1—malignant glioma	8.74e-06	0.000222	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—malignant glioma	8.72e-06	0.000221	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—IDH2—malignant glioma	8.67e-06	0.00022	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.63e-06	0.000219	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CAT—malignant glioma	8.48e-06	0.000215	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS1—malignant glioma	8.19e-06	0.000208	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.15e-06	0.000207	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NCOR1—malignant glioma	8.01e-06	0.000203	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.86e-06	0.000199	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BCHE—malignant glioma	7.61e-06	0.000193	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.59e-06	0.000192	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC5A5—malignant glioma	7.52e-06	0.000191	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—IDH1—malignant glioma	7.45e-06	0.000189	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTT1—malignant glioma	7.4e-06	0.000188	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SPHK1—malignant glioma	7.21e-06	0.000183	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.07e-06	0.000179	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS1—malignant glioma	6.94e-06	0.000176	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.91e-06	0.000175	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CAV1—malignant glioma	6.53e-06	0.000165	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BCHE—malignant glioma	6.45e-06	0.000163	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC5A5—malignant glioma	6.37e-06	0.000161	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—malignant glioma	6.06e-06	0.000154	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.03e-06	0.000153	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.97e-06	0.000151	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CG—malignant glioma	5.95e-06	0.000151	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CAT—malignant glioma	5.9e-06	0.000149	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPARG—malignant glioma	5.74e-06	0.000145	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTT1—malignant glioma	5.71e-06	0.000145	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NCOR1—malignant glioma	5.57e-06	0.000141	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS1—malignant glioma	5.36e-06	0.000136	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CD—malignant glioma	5.23e-06	0.000133	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.21e-06	0.000132	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—malignant glioma	5.13e-06	0.00013	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CAT—malignant glioma	4.99e-06	0.000127	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BCHE—malignant glioma	4.98e-06	0.000126	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.92e-06	0.000125	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NCOR1—malignant glioma	4.72e-06	0.00012	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.56e-06	0.000116	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CAV1—malignant glioma	4.54e-06	0.000115	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—malignant glioma	4.52e-06	0.000114	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.13e-06	0.000105	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPARG—malignant glioma	3.99e-06	0.000101	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—malignant glioma	3.96e-06	0.0001	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTEN—malignant glioma	3.94e-06	9.98e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CAT—malignant glioma	3.85e-06	9.77e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CAV1—malignant glioma	3.84e-06	9.74e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.67e-06	9.31e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.64e-06	9.23e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.63e-06	9.21e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.5e-06	8.88e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPARG—malignant glioma	3.38e-06	8.57e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.17e-06	8.03e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.14e-06	7.95e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.08e-06	7.8e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CAV1—malignant glioma	2.97e-06	7.52e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.78e-06	7.04e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTEN—malignant glioma	2.74e-06	6.94e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.7e-06	6.85e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.68e-06	6.8e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—malignant glioma	2.66e-06	6.74e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPARG—malignant glioma	2.61e-06	6.61e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.38e-06	6.02e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTEN—malignant glioma	2.32e-06	5.88e-05	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—malignant glioma	2.27e-06	5.75e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.07e-06	5.25e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.05e-06	5.2e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.93e-06	4.89e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTEN—malignant glioma	1.79e-06	4.54e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.64e-06	4.15e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—malignant glioma	1.58e-06	4e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—malignant glioma	1.34e-06	3.39e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.26e-06	3.2e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—malignant glioma	1.03e-06	2.61e-05	CbGpPWpGaD
